American Society of Hematology: Genetic Profile Correlates With Better Response to Treatment for Myeloproliferative Neoplasms
December 11, 2024
December 11, 2024
WASHINGTON, Dec. 11 (TNSres) -- The American Society of Hematology issued the following news release:
* * *
Variants could serve as biomarker to inform prognosis or guide treatment decisions
LBA-4: Andean Enriched NFKB1 Haplotype Reduces Inflammation and Improves Response to Ropeginterferon Alfa-2b in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
* * *
(SAN DIEGO - Dec. 10, 2024) - A study presented during the 66th Amer . . .
* * *
Variants could serve as biomarker to inform prognosis or guide treatment decisions
LBA-4: Andean Enriched NFKB1 Haplotype Reduces Inflammation and Improves Response to Ropeginterferon Alfa-2b in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
* * *
(SAN DIEGO - Dec. 10, 2024) - A study presented during the 66th Amer . . .